Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug.
暂无分享,去创建一个
Jing Wang | Siling Wang | Tong-ying Jiang | Siling Wang | Jing Wang | Tongying Jiang | Yanchen Hu | Zhuangzhi Zhi | Zhuangzhi Zhi | Y. Hu
[1] C. A. Russell,et al. Cationic phosphorus-carbon-pnictogen cages isolobal to [C5R5]+. , 2006, Chemical Communications.
[2] G. Mul,et al. Mesoporous silica material TUD-1 as a drug delivery system. , 2007, International journal of pharmaceutics.
[3] Jenny Andersson,et al. Influences of Material Characteristics on Ibuprofen Drug Loading and Release Profiles from Ordered Micro- and Mesoporous Silica Matrices , 2004 .
[4] Patrick Augustijns,et al. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. , 2007, Chemical communications.
[5] Ö. Dag,et al. The effect of cationic surfactant and some organic/inorganic additives on the morphology of mesostructured silica templated by pluronics , 2008 .
[6] María Vallet-Regí,et al. Sol-gel silica-based biomaterials and bone tissue regeneration. , 2010, Acta biomaterialia.
[7] Xiaofen Li,et al. Bio-templated synthesis of highly ordered macro-mesoporous silica material for sustained drug delivery , 2010 .
[8] Yuhan Sun,et al. Controllable release of ibuprofen from size-adjustable and surface hydrophobic mesoporous silica spheres , 2009 .
[9] G. Kalies,et al. Liquid adsorption of n-octane/octanol/ethanol on SBA-16 silica. , 2007, Journal of colloid and interface science.
[10] I. Smirnova,et al. Adsorption of Drugs on Silica Aerogels , 2003 .
[11] H. Santos,et al. Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[12] T. Asefa,et al. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs. , 2010, ACS nano.
[13] Qinghu Tang,et al. Mesostructured SBA-16 with excellent hydrothermal, thermal and mechanical stabilities: modified synthesis and its catalytic application. , 2009, Journal of colloid and interface science.
[14] J. M. Córdoba,et al. Influence of synthesis temperature on morphology of SBA-16 mesoporous materials with a three-dimensional pore system , 2010 .
[15] Thomas Rades,et al. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[16] P. Kallinteri,et al. Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. , 2010, International journal of pharmaceutics.
[17] María Vallet-Regí,et al. Drug delivery from ordered mesoporous matrices , 2009, Expert opinion on drug delivery.
[18] M. Jaroniec,et al. Tailoring the Pore Structure of SBA-16 Silica Molecular Sieve through the Use of Copolymer Blends and Control of Synthesis Temperature and Time , 2004 .
[19] R. Denoyel,et al. Impregnation of vitamin E acetate on silica mesoporous phases using supercritical carbon dioxide , 2009 .
[20] He Hui,et al. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. , 2010, Molecular pharmaceutics.
[21] F. Marmottini,et al. Role of mesoporous silicates on carbamazepine dissolution rate enhancement , 2008 .
[22] D. Quintanar-Guerrero,et al. Silica xerogels as pharmaceutical drug carriers , 2009 .
[23] E. Rivera-Muñoz,et al. Sol Gel-Derived SBA-16 Mesoporous Material , 2010, International journal of molecular sciences.
[24] A. Garjani,et al. Enhancement of Dissolution Rate and Anti-inflammatory Effects of Piroxicam Using Solvent Deposition Technique , 2002, Drug development and industrial pharmacy.
[25] Bruno C. Hancock,et al. What is the True Solubility Advantage for Amorphous Pharmaceuticals? , 2000, Pharmaceutical Research.
[26] Ludo Froyen,et al. Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[27] G. van Tendeloo,et al. Investigation of the morphology of the mesoporous SBA-16 and SBA-15 materials. , 2006, The journal of physical chemistry. B.
[28] Bradley F. Chmelka,et al. Nonionic Triblock and Star Diblock Copolymer and Oligomeric Surfactant Syntheses of Highly Ordered, Hydrothermally Stable, Mesoporous Silica Structures , 1998 .
[29] R. Tan,et al. Stabilized amorphous state of ibuprofen by co-spray drying with mesoporous SBA-15 to enhance dissolution properties. , 2010, Journal of pharmaceutical sciences.
[30] Wendy I. Wilson,et al. Investigation of drug-porous adsorbent interactions in drug mixtures with selected porous adsorbents. , 2007, Journal of pharmaceutical sciences.
[31] Wei-hai Shi,et al. Ordered large-pore mesoporous silica film with Im3m symmetry synthesized in ternary copolymer–butanol–water system , 2006 .
[32] M. Vallet‐Regí,et al. Bioceramics and pharmaceuticals: A remarkable synergy , 2007 .
[33] Yasuhiro Sakamoto,et al. Direct imaging of the pores and cages of three-dimensional mesoporous materials , 2000, Nature.
[34] Joël Patarin,et al. Morphology and porosity characteristics control of SBA-16 mesoporous silica. Effect of the triblock surfactant Pluronic F127 degradation during the synthesis , 2005 .
[35] Dongyuan Zhao,et al. Hexagonal to Mesocellular Foam Phase Transition in Polymer-Templated Mesoporous Silicas , 2000 .
[36] P. Voort,et al. Rationalization of the Synthesis of SBA-16: Controlling the Micro- and Mesoporosity , 2002 .
[37] Dongyuan Zhao,et al. Morphological Control of Highly Ordered Mesoporous Silica SBA-15 , 2000 .
[38] V. S. Lin,et al. Mesoporous silica nanoparticles deliver DNA and chemicals into plants. , 2007, Nature nanotechnology.
[39] M. Vallet‐Regí,et al. Influence of pore size of MCM-41 matrices on drug delivery rate , 2004 .
[40] M. Vallet‐Regí,et al. A New Property of MCM-41: Drug Delivery System , 2001 .
[41] I. Smirnova,et al. Dissolution Rate Enhancement by Adsorption of Poorly Soluble Drugs on Hydrophilic Silica Aerogels , 2005, Pharmaceutical development and technology.
[42] Brian G. Trewyn,et al. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration , 2008 .
[43] R. Forbes,et al. Disorder and dissolution enhancement: deposition of ibuprofen on to insoluble polymers. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[44] Shaobin Wang,et al. Ordered mesoporous materials for drug delivery , 2009 .
[45] Y. Sakamoto,et al. Immobilization of lipase in ordered mesoporous materials: Effect of textural and structural parameters , 2008 .
[46] Shilun Qiu,et al. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica , 2006 .
[47] G. Mul,et al. Evaluation of Mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 Materials as API Carriers for Oral Drug Delivery , 2007, Drug delivery.
[48] Juan L. Vivero-Escoto,et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. , 2008, Advanced drug delivery reviews.
[49] Patrick Augustijns,et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[50] V. Crocellà,et al. Controlled release of metoprolol tartrate from nanoporous silica matrices , 2010 .
[51] V. Meynen,et al. Verified syntheses of mesoporous materials , 2009 .
[52] Patrick Augustijns,et al. Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs. , 2009, Journal of pharmaceutical sciences.
[53] J. Devoisselle,et al. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[54] S. Qiu,et al. A controlled release of ibuprofen by systematically tailoring the morphology of mesoporous silica materials , 2006 .
[55] C Rossi,et al. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[56] Qiang Cai,et al. Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium , 2001 .